Covance, LabCorp’s Drug Development Business, Acclaimed by Frost & Sullivan for Its Unmatched Breadth of Services to Support Clinical Trials
Frost & Sullivan
DECEMBER 16, 2020
Based on its recent analysis of the global contract research organization (CRO) market, Frost & Sullivan recognizes LabCorp’s drug development business, Covance, with the 2020 Global CRO Company of the Year Award. Contact us: Start the discussion. Contact: Lindsey Whitaker. P: +1 (210) 477-8457. About LabCorp.
Let's personalize your content